Citations (27)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Xudong Zhang, Lu Zhao, Changying Chen, Jiaqin Yan, Chaofeng Zhou, Guangxing Yue, Li Tian & Mingzhi Zhang. (2012) The effect of lentivirus-mediated expression of tumor necrosis factor related apoptosis-inducing ligand and shRNA against Bcl-2 on the growth of lymphoma cells. Leukemia & Lymphoma 53:4, pages 710-717.
Read now
Read now
Seok Jin Kim & Jong Ho Won. (2012) B cell homeostasis and the development of chronic graft-versus-host disease: implications for B cell-depleting therapy. Leukemia & Lymphoma 53:1, pages 19-25.
Read now
Read now
Articles from other publishers (25)
Perla R. Colunga-Pedraza, Luz María Barbosa-Castillo, Edgar Ulises Coronado-Alejandro, Héctor Alejandro Vaquera-Alfaro, Ingrid Gabriela López-Reyna, Julia E. Colunga-Pedraza & David Gómez-Almaguer. (2023) Low-dose rituximab in steroid-refractory chronic graft-versus-host disease. Transplant Immunology 81, pages 101959.
Crossref
Crossref
Ragisha Gopalakrishnan & Madan Jagasia. 2019. Hematopoietic Cell Transplantation for Malignant Conditions. Hematopoietic Cell Transplantation for Malignant Conditions
301
319
.
Sue-Ching Yeoh, Hong Hua, Juan Fernando Yepes & Douglas E. Peterson. 2019. Contemporary Oral Medicine. Contemporary Oral Medicine
1523
1639
.
Zarir Ahmed, Martin Schoen & Nabeel Rajeh. (2018) Myasthenia Gravis Presenting as Graft versus Host Disease after Allogeneic Blood Stem Cell Transplant. Case Reports in Hematology 2018, pages 1-3.
Crossref
Crossref
Sue-Ching Yeoh, Hong Hua, Juan Fernando Yepes & Douglas E. Peterson. 2018. Contemporary Oral Medicine. Contemporary Oral Medicine
1
117
.
Kyle R. Brownback, Laura A. Thomas, Joseph P. McGuirk, Siddhartha Ganguly, Christopher Streiler & Sunil Abhyankar. (2017) Effect of Rituximab on Pulmonary Function in Bronchiolitis Obliterans Syndrome due to Graft-Versus-Host-Disease. Lung 195:6, pages 781-788.
Crossref
Crossref
Jerrad M. Stoddard, Tamera Plair & Yvonne H. Jee. (2016) Management of Graft-Versus-Host Disease. Physician Assistant Clinics 1:3, pages 419-433.
Crossref
Crossref
Salyka Sengsayadeth & Wichai Chinratanalab. 2015. Clinical Guide to Transplantation in Lymphoma. Clinical Guide to Transplantation in Lymphoma
133
144
.
Hideki Nakasone, Bita Sahaf & David B. Miklos. (2015) Therapeutic benefits targeting B-cells in chronic graft-versus-host disease. International Journal of Hematology 101:5, pages 438-451.
Crossref
Crossref
Chitra Clive Ganta, Soumya Chatterjee, Brad Pohlman & Mehrnaz Hojjati. (2015) Chronic Graft-Versus-Host Disease Presenting as Eosinophilic Fasciitis. JCR Journal of Clinical Rheumatology 21:2, pages 86-94.
Crossref
Crossref
Jung-Yeon Lim, Min-Jung Park, Keon-Il Im, Nayoun Kim, Hyun-Sil Park, Sung-Hee Lee, Eun-Kung Kim, Young-Sun Nam, Eun-Sol Lee, Mi-La Cho & Seok-Goo Cho. (2015) Interleukin 21 blockade modulates activated T- and B-cell homeostasis via B-cell activating factor pathway–mediated inhibition in a murine model of acute graft-versus-host disease. Experimental Hematology 43:1, pages 23-31.e2.
Crossref
Crossref
Øystein Bruserud, Tor Henrik Anderson Tvedt, Petter Quist Paulsen, Aymen Bushra Ahmed, Tobias Gedde-Dahl, Geir E. Tjønnfjord, Heidi Slåstad, Dag Heldal & Håkon Reikvam. (2014) Extracorporeal photopheresis (photochemotherapy) in the treatment of acute and chronic graft versus host disease: immunological mechanisms and the results from clinical studies. Cancer Immunology, Immunotherapy 63:8, pages 757-777.
Crossref
Crossref
Sule Unal, Erdal Sag, Baris Kuskonmaz, Selman Kesici, Benan Bayrakci, Deniz C. Ayvaz, Ilhan Tezcan, Dilek Yalnızoglu & Duygu Uckan. (2014) Successful treatment of severe myasthenia gravis developed after allogeneic hematopoietic stem cell transplantation with plasma exchange and rituximab. Pediatric Blood & Cancer 61:5, pages 928-930.
Crossref
Crossref
Salyka M. Sengsayadeth, Shivani Srivastava, Madan Jagasia & Bipin N. Savani. (2012) Time to Explore Preventive and Novel Therapies for Bronchiolitis Obliterans Syndrome after Allogeneic Hematopoietic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation 18:10, pages 1479-1487.
Crossref
Crossref
H H Uhlving, F Buchvald, C J Heilmann, K G Nielsen, M Gormsen & K G Müller. (2011) Bronchiolitis obliterans after allo-SCT: clinical criteria and treatment options. Bone Marrow Transplantation 47:8, pages 1020-1029.
Crossref
Crossref
Mark Bosch, Faisal M. Khan & Jan Storek. (2012) Immune reconstitution after hematopoietic cell transplantation. Current Opinion in Hematology 19:4, pages 324-335.
Crossref
Crossref
X Chen, C-H Chang, R Stein & D M Goldenberg. (2011) The humanized anti-HLA-DR moAb, IMMU-114, depletes APCs and reduces alloreactive T cells: implications for preventing GVHD. Bone Marrow Transplantation 47:7, pages 967-980.
Crossref
Crossref
Eugene Y. Chiang, Ganesh Kolumam, Krista M. McCutcheon, Judy Young, Zhonghua Lin, Mercedesz Balazs & Jane L. Grogan. (2012) In Vivo Depletion of Lymphotoxin-Alpha Expressing Lymphocytes Inhibits Xenogeneic Graft-versus-Host-Disease. PLoS ONE 7:3, pages e33106.
Crossref
Crossref
Yoshihisa Morishita & Yoshihiro Inamoto. (2012) Management of Chronic Graft-versus-Host Disease 2012. Journal of Hematopoietic Cell Transplantation 1:2, pages 37-51.
Crossref
Crossref
Yoshihiro Inamoto & Mary E.D. Flowers. (2011) Treatment of chronic graft-versus-host disease in 2011. Current Opinion in Hematology 18:6, pages 414-420.
Crossref
Crossref
Akiko Mii, Akira Shimizu, Tomohiro Kaneko, Emiko Fujita, Megumi Fukui, Teppei Fujino, Kouichi Utsumi, Hiroki Yamaguchi, Kenji Tajika, Shin‐ichi Tsuchiya, Yasuhiko Iino, Yasuo Katayama & Yuh Fukuda. (2011) Renal thrombotic microangiopathy associated with chronic graft‐versus‐host disease after allogeneic hematopoietic stem cell transplantation. Pathology International 61:9, pages 518-527.
Crossref
Crossref
Nishitha Reddy, Katayoun Rezvani, A. John Barrett & Bipin N. Savani. (2011) Strategies to Prevent EBV Reactivation and Posttransplant Lymphoproliferative Disorders (PTLD) after Allogeneic Stem Cell Transplantation in High-Risk Patients. Biology of Blood and Marrow Transplantation 17:5, pages 591-597.
Crossref
Crossref
Chang-Ki Min. (2011) The pathophysiology of chronic graft-versus-host disease: the unveiling of an enigma. The Korean Journal of Hematology 46:2, pages 80.
Crossref
Crossref
Akiko Mii, Akira Shimizu, Yukinari Masuda, Teppei Fujino, Tomohiro Kaneko, Kouichi Utsumi, Takashi Arai, Arimi Ishikawa, Kyoko Wakamatsu, Kenji Tajika, Yasuhiko Iino, Yasuo Katayama & Yuh Fukuda. (2011) Renal thrombotic microangiopathy associated with chronic humoral graft versus host disease after hematopoietic stem cell transplantation. Pathology International 61:1, pages 34-41.
Crossref
Crossref
David L. Porter, Edwin P. Alyea, Joseph H. Antin, Marcos DeLima, Eli Estey, J.H. Frederik Falkenburg, Nancy Hardy, Nicolaus Kroeger, Jose Leis, John Levine, David G. Maloney, Karl Peggs, Jacob M. Rowe, Alan S. Wayne, Sergio Giralt, Michael R. Bishop & Koen van Besien. (2010) NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: Report from the Committee on Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation 16:11, pages 1467-1503.
Crossref
Crossref